News on haematological malignancies
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukaemia and lymphoma
According to results from a Phase I/IIa trial at The University of Texas MD Anderson…
News on haematological malignancies
According to results from a Phase I/IIa trial at The University of Texas MD Anderson…
A genetic mutation that disrupts how DNA sends messages to the rest of a cell…
Study identifying mechanism that prevents cell death may guide future immunotherapy strategies Some cancer cells…
Researchers have discovered ways to boost CAR T-cell therapy. According to a study published in…
Today, OncoTartis, Inc. and Children’s Cancer Institute jointly announced the publication of two research manuscripts…
Peter Mac scientists have found a way to target acute myeloid leukemia (AML) at its…
A massive research effort over more than a quarter century has tried to make personalised…
A stem cell transplant – also called a bone marrow transplant – is a common…
Ingo Ringshausen, University of Cambridge Cancer of the immune system, lymphoma or leukaemia, generally affects…
Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow…